SAN FRANCISCO, July 31, 2023 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological disorders, today announced the appointment of James Stutz, a business and finance executive with over 20 years of experience in the biopharma industry, as chief financial officer (CFO) and chief business officer (CBO). “We are delighted to welcome James to the Neurona team and look forward to the value he

Related Keywords

United States , Essex , California , James Stutz , Coryr Nicholas , Alios Biopharma , Elizabeth Wolffe , Sylvia Wheeler , Janssen Pharmaceutical Companies Of Johnson , Essex Woodlands Health Ventures , Strategic Decisions Group , University Of California At Santa Barbara , United States Air , Tuck School Of Business At Dartmouth , Actym Therapeutics , Instil Bio , Janssen Pharmaceutical Companies , Revance Therapeutics , Thermo Fisher Scientific , Tuck School , Media Contacts ,